| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.34 | 0.05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.33 | 0.07 |